Revive Biotechnology

United States
Champaign, Illinois, United States, 61820

Company profile

Revive Biotechnology company profile

Revive Biotechnology improves oxygen delivery to hypoxic tissues by utilizing innovative nanotechnology. Research and development is currently focused on treatment for central retinal artery occlusion with potential future applications for additional ocular ischemic conditions.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2018-01-01, Year

Headquarters

Postal code
61820
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $256,000 / 2020-11-24
Investors
1
Lead investors
1

Founders and investors

Lead investors

National Science Foundation

Investors

National Science Foundation